Lipids in Health and Disease,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: May 21, 2024
Abstract
Background
Alzheimer’s
disease
(AD)
is
a
chronic
neurodegenerative
disorder
that
poses
substantial
economic
burden.
The
Random
forest
algorithm
effective
in
predicting
AD;
however,
the
key
factors
influencing
AD
onset
remain
unclear.
This
study
aimed
to
analyze
lipoprotein
and
metabolite
using
machine-learning
methods.
It
provides
new
insights
for
researchers
medical
personnel
understand
reference
early
diagnosis,
treatment,
prevention
of
AD.
Methods
A
total
603
participants,
including
controls
patients
with
complete
data
from
Neuroimaging
Initiative
(ADNI)
database
between
2005
2016,
were
enrolled.
forest,
Lasso
regression,
CatBoost
algorithms
employed
rank
filter
213
variables.
Variables
consistently
high
importance
rankings
any
two
methods
incorporated
into
models.
Finally,
variables
selected
three
methods,
participants’
age,
sex,
marital
status,
used
construct
random
predictive
model.
Results
Fourteen
screened
17
included
prediction
model
based
on
status
participants.
optimal
modeling
was
constructed
“mtry”
set
3
“ntree”
300.
exhibited
an
accuracy
71.01%,
sensitivity
79.59%,
specificity
65.28%,
AUC
(95%CI)
0.724
(0.645–0.804).
When
Mean
Decrease
Accuracy
Gini
proteins,
phospholipids
lipids
ratio
intermediate-density
lipoproteins
(IDL_PL_PCT),
creatinine
among
top
five
Conclusions
Age,
IDL_PL_PCT,
levels
play
crucial
roles
onset.
Regular
monitoring
their
metabolites
older
individuals
significant
diagnosis
prevention.
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(4), P. 1264 - 1285
Published: Jan. 1, 2023
With
the
increase
of
population
aging,
number
Alzheimer's
disease
(AD)
patients
is
also
increasing.According
to
current
estimates,
approximately
11%
people
over
65
suffer
from
AD,
and
that
percentage
rises
42%
among
85.However,
no
effective
treatment
capable
decelerating
or
stopping
AD
progression
available.Furthermore,
AD-targeted
drugs
composed
synthetic
molecules
pose
concerns
regarding
biodegradation,
clearance,
immune
response,
neurotoxicity.Mesenchymal
stem
cell-derived
extracellular
vesicles
(MSC-EVs)
are
essential
intercellular
communication
mediators
holding
great
promise
as
therapeutics
owing
their
biocompatibility,
versatility,
effortless
storage,
superior
safety,
ability
transport
messenger
noncoding
RNAs,
proteins,
lipids,
DNAs,
other
bioactive
compounds
derived
cells.The
functionalisation
engineering
strategies
MSC-EVs
highlighted
(e.g.preconditioning,
drug
loading,
surface
modification,
artificial
EV
fabrication),
which
could
improve
by
multiple
therapeutic
effects,
including
clearing
abnormal
protein
accumulation
achieving
neuroprotection
immunomodulatory
effects.Herein,
this
review
summarises
state-of-the-art
engineer
MSC-EVs,
discusses
progress
in
use
therapeutics,
presents
perspectives
challenges
associated
with
related
clinical
applications,
concludes
engineered
show
immense
potential
therapy.
Nature Aging,
Journal Year:
2024,
Volume and Issue:
4(3), P. 379 - 395
Published: Feb. 21, 2024
Identification
of
Alzheimer's
disease
(AD)
onset
risk
can
facilitate
interventions
before
irreversible
progression.
We
demonstrate
that
electronic
health
records
from
the
University
California,
San
Francisco,
followed
by
knowledge
networks
(for
example,
SPOKE)
allow
for
(1)
prediction
AD
and
(2)
prioritization
biological
hypotheses,
(3)
contextualization
sex
dimorphism.
trained
random
forest
models
predicted
on
a
cohort
749
individuals
with
250,545
controls
mean
area
under
receiver
operating
characteristic
0.72
(7
years
prior)
to
0.81
(1
day
prior).
further
harnessed
matched
identify
conditions
predictive
power
onset.
Knowledge
highlight
shared
genes
between
multiple
top
predictors
APOE,
ACTB,
IL6
INS).
Genetic
colocalization
analysis
supports
association
hyperlipidemia
at
APOE
locus,
as
well
stronger
female
osteoporosis
locus
near
MS4A6A.
therefore
show
how
clinical
data
be
utilized
early
identification
personalized
hypotheses.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(10), P. 2049 - 2049
Published: Oct. 18, 2022
In
the
last
few
decades,
endocannabinoids,
plant-derived
cannabinoids
and
synthetic
have
received
growing
interest
as
treatment
options
in
neurodegenerative
conditions.
various
experimental
settings,
they
displayed
antioxidative,
anti-inflammatory,
antiapoptotic,
immunomodulatory,
neuroprotective
effects.
However,
due
to
numerous
targets
downstream
effectors
of
their
action,
cellular
molecular
mechanisms
underlying
these
effects
are
rather
complex
still
under
discussion.
Cannabinoids
able
neutralize
free
radicals
modulate
production
reactive
oxygen
species
activity
antioxidative
systems
acting
on
CB1
CB2
cannabinoid
receptors.
The
activation
receptors
stimulates
signaling
pathways
involved
defense
survival
(such
phosphoinositide
3-kinase
(PI3K)/Akt,
mitogen-activated
protein
kinase
(MAPK),
Nrf2
pathways)
regulates
glutamatergic
signaling,
N-methyl-D-aspartate
(NMDA)
receptors,
calcium
influx,
induction
Ca2+-regulated
cascades,
whereas
mediated
by
suppression
microglial
release
prooxidative
proinflammatory
mediators.
This
review
summarizes
main
new
advances
understanding
cannabinoids.
Because
plethora
possible
pharmacological
interventions
related
oxidative
stress
cannabinoid-mediated
neuroprotection,
future
research
should
be
directed
towards
a
better
interplay
between
activated
signal
transduction
with
aim
improve
efficacy
targeting
endocannabinoid
system.
Alzheimer s & Dementia,
Journal Year:
2023,
Volume and Issue:
20(1), P. 709 - 727
Published: Oct. 9, 2023
Abstract
Aging,
tau
pathology,
and
chronic
inflammation
in
the
brain
play
crucial
roles
synaptic
loss,
neurodegeneration,
cognitive
decline
tauopathies,
including
Alzheimer's
disease.
Senescent
cells
accumulate
aging
brain,
accelerate
process,
promote
tauopathy
progression
through
their
abnormal
inflammatory
secretome
known
as
senescence‐associated
secretory
phenotype
(SASP).
Tau
oligomers
(TauO)—the
most
neurotoxic
species—are
to
induce
senescence
SASP,
which
subsequently
neuropathology,
inflammation,
oxidative
stress,
dysfunction,
neuronal
death,
dysfunction.
TauO,
are
associated
with
heterogeneity
decline.
However,
underlying
mechanisms
driving
disease
remain
largely
unknown,
impeding
development
of
therapies
for
tauopathies.
Based
on
clinical
preclinical
evidence,
this
review
highlights
critical
role
TauO
neurodegeneration.
We
discuss
key
knowledge
gaps
potential
strategies
targeting
treat
Highlights
Senescence,
oligomeric
(TauO),
process
contributing
highlight
target
tauopathies
while
addressing
gaps.
Journal of Alzheimer s Disease,
Journal Year:
2023,
Volume and Issue:
96(4), P. 1353 - 1382
Published: Nov. 7, 2023
Diet
is
an
important
nonpharmacological
risk-modifying
factor
for
Alzheimer's
disease
(AD).
The
approaches
used
here
to
assess
diet's
role
in
the
risk
of
AD
include
multi-country
ecological
studies,
prospective
and
cross-sectional
observational
laboratory
studies.
Ecological
studies
have
identified
fat,
meat,
obesity
from
high-energy
diets
as
factors
reported
that
rates
peak
about
15-20
years
after
national
dietary
changes.
Observational
compared
Western
pattern
with
those
Dietary
Approaches
Stop
Hypertension
(DASH),
Mediterranean
(MedDi),
Mediterranean-DASH
Intervention
Neurodegenerative
Delay
(MIND)
diets.
Those
including
higher
consumption
saturated
total
fats,
ultraprocessed
foods
a
lower
fruits,
legumes,
nuts,
omega-3
fatty
acids,
vegetables,
whole
grains.
Diet-induced
associated
significant
inflammation,
insulin
resistance,
oxidative
stress,
elevated
homocysteine,
advanced
glycation
end
products,
trimethylamine
N-oxide.
molecular
mechanisms
by
which
bioactive
components
specific
affect
are
discussed.
Given
most
countries'
entrenched
food
supply
systems,
upward
trends
would
be
hard
reverse.
However,
people
willing
able,
low-animal
product
diet
plenty
anti-inflammatory,
low-glycemic
load
may
helpful.
Journal of Alzheimer s Disease,
Journal Year:
2024,
Volume and Issue:
97(3), P. 977 - 1005
Published: Jan. 9, 2024
High
dietary
intake
of
saturated
fatty
acids
is
a
suspected
risk
factor
for
neurodegenerative
diseases,
including
Alzheimer’s
disease
(AD).
To
decipher
the
causal
link
behind
these
associations,
high-fat
diets
(HFD)
have
been
repeatedly
investigated
in
animal
models.
Preclinical
studies
allow
full
control
over
composition,
avoiding
ethical
concerns
clinical
trials.
The
goal
present
article
to
provide
narrative
review
reports
on
HFD
models
AD.
Eligibility
criteria
included
mouse
AD
fed
defined
as
>
35%
fat/weight
and
western
containing
1%
cholesterol
or
15%
sugar.
MEDLINE
Embase
databases
were
searched
from
1946
August
2022,
32
preclinical
review.
HFD-induced
obesity
metabolic
disturbances
such
insulin
resistance
glucose
intolerance
replicated
most
studies,
but
with
methodological
variability.
Most
found
an
aggravating
effect
brain
Aβ
pathology,
whereas
tau
pathology
has
much
less
studied,
results
are
more
equivocal.
While
show
impairment
cognitive
behavior,
confounding
factors
may
blur
their
interpretation.
In
summary,
despite
conflicting
results,
exposing
rodents
highly
enriched
fat
induces
not
only
defects,
also
often
accompanied
by
aggravated
neuropathological
markers,
notably
burden.
Although
there
important
variations
between
methods,
particularly
lack
diet
characterization,
collectively
suggest
that
excessive
should
be
avoided
order
lower
incidence
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(10), P. 1208 - 1208
Published: Oct. 8, 2024
Alzheimer's
disease
(AD)
is
a
progressive
neurodegenerative
disease,
and
it
currently
the
seventh
leading
cause
of
death
worldwide.
It
characterized
by
extracellular
aggregation
amyloid
β-peptide
(Aβ)
into
oligomers
fibrils
that
synaptotoxicity
neuronal
death.
Aβ
exhibits
dual
role
in
promoting
oxidative
stress
inflammation.
This
review
aims
to
unravel
intricate
connection
between
these
processes
their
contribution
AD
progression.
The
delves
AD,
focusing
on
involvement
metals,
mitochondrial
dysfunction,
biomolecule
oxidation.
distinct
yet
overlapping
concept
nitro-oxidative
also
discussed,
detailing
roles
nitric
oxide,
perturbations,
cumulative
impact
production
neurotoxicity.
Inflammation
examined
through
astroglia
microglia
function,
elucidating
response
within
brain.
blood-brain
barrier
oligodendrocytes
are
considered
context
pathophysiology.
We
current
diagnostic
methodologies
emerging
therapeutic
strategies
aimed
at
mitigating
inflammation,
thereby
offering
potential
treatments
for
halting
or
slowing
comprehensive
synthesis
underscores
pivotal
bridging
advancing
our
understanding
informing
future
research
treatment
paradigms.
Current Osteoporosis Reports,
Journal Year:
2024,
Volume and Issue:
22(1), P. 165 - 176
Published: Jan. 29, 2024
Abstract
Purpose
of
Review
This
review
examines
the
linked
pathophysiology
Alzheimer’s
disease/related
dementia
(AD/ADRD)
and
bone
disorders
like
osteoporosis.
The
emphasis
is
on
“inflammaging”—a
low-level
inflammation
common
to
both,
its
implications
in
an
aging
population.
Recent
Findings
Aging
intensifies
both
ADRD
deterioration.
Notably,
patients
have
a
heightened
fracture
risk,
impacting
morbidity
mortality,
though
it
uncertain
if
fractures
worsen
ADRD.
Therapeutically,
agents
targeting
pathways,
especially
Nuclear
factor
kappa-light-chain-enhancer
activated
B
cells
(NF-kB)
TNF-α,
appear
beneficial
for
conditions.
Additionally,
treatments
Sirtuin
1
(SIRT-1),
known
anti-inflammatory
neuroprotective
properties,
are
gaining
attention.
Summary
interconnectedness
AD/ADRD
health
necessitates
unified
treatment
approach.
By
addressing
shared
mechanisms,
we
can
potentially
transform
therapeutic
strategies,
enriching
our
understanding
refining
care
society.
article
part
series
multiple
manuscripts
designed
determine
utility
using
artificial
intelligence
writing
scientific
reviews.
Neurotherapeutics,
Journal Year:
2024,
Volume and Issue:
21(6), P. e00470 - e00470
Published: Oct. 1, 2024
Multiple
studies
over
the
last
decade
have
established
that
Alzheimer's
disease
and
related
dementias
(ADRD)
are
associated
with
changes
in
gut
microbiome.
These
alterations
organismal
composition
result
abundances
of
functions
encoded
by
microbial
community,
including
metabolic
capabilities,
which
likely
impact
host
mechanisms.
Gut
microbes
access
dietary
components
other
molecules
made
produce
metabolites
can
enter
circulation
cross
blood-brain
barrier
(BBB).
In
recent
years,
several
been
or
shown
to
influence
pathways
relevant
ADRD
pathology.
include
short
chain
fatty
acids,
secondary
bile
tryptophan
derivatives
(such
as
kynurenine,
serotonin,
tryptamine,
indoles),
trimethylamine/trimethylamine
N-oxide.
Notably,
some
these
BBB
various
effects
on
brain,
modulating
release
neurotransmitters
neuronal
function,
inducing
oxidative
stress
inflammation,
impacting
synaptic
function.
Microbial
also
central
nervous
system
through
immune,
enteroendocrine,
enteric
pathways,
perturbations
turn
function
peripheral
immune
responses,
well
integrity,
homeostasis
neurogenesis,
glial
cell
maturation
activation.
This
review
examines
evidence
supporting
notion
is
influenced
microbiota
its
metabolites.
The
potential
therapeutic
advantages
for
preventing
treating
discussed,
highlighting
their
role
developing
new
treatments.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(10), P. 2413 - 2413
Published: May 22, 2023
The
emphasis
on
healthy
nutrition
is
gaining
a
forefront
place
in
current
biomedical
sciences.
Nutritional
deficiencies
and
imbalances
have
been
widely
demonstrated
to
be
involved
the
genesis
development
of
many
world-scale
public
health
burdens,
such
as
metabolic
cardiovascular
diseases.
In
recent
years,
bee
pollen
emerging
scientifically
validated
candidate,
which
can
help
diminish
conditions
through
nutritional
interventions.
This
matrix
being
extensively
studied,
has
proven
very
rich
well-balanced
nutrient
pool.
this
work,
we
reviewed
available
evidence
interest
source.
We
mainly
focused
richness
nutrients
its
possible
roles
main
pathophysiological
processes
that
are
directly
linked
imbalances.
scoping
review
analyzed
scientific
works
published
last
four
focusing
clearest
inferences
perspectives
translate
cumulated
experimental
preclinical
into
clinically
relevant
insights.
promising
uses
for
malnutrition,
digestive
health,
disorders,
other
bioactivities
could
helpful
readjust
homeostasis
(as
it
also
true
case
anti-inflammatory
or
anti-oxidant
needs),
well
benefits
diseases,
were
identified.
knowledge
gaps
identified,
along
with
practical
challenges
hinder
establishment
fructification
these
uses.
A
complete
data
collection
made
major
range
botanical
species
allows
more
robust
clinical
information.